Paul Horn

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (9)

Roland Eils

University of Heidelberg Bioquant

GERMANY

View details

Rajeshwar Prosad Mookerjee

UNITED KINGDOM

View details

Emma Shepherd

Aston University

UNITED KINGDOM

View details

Moritz Peiseler

Charité - Universitätsmedizin Berlin

GERMANY

View details

Christoph Sponholz

Jena University Hospital

GERMANY

View details

Jens Haueisen

Professor at Ilmenau University of Technology

Ilmenau University of Technology

GERMANY

View details

Wim Laleman

BELGIUM

View details

Frank Tacke

GERMANY

View details

Juan Acevedo

University Hospitals Plymouth NHS Trust

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paul Horn

Research Interests

Explore related searches

Contact this professor

Articles (24)

2D, or not 2D? Investigating Vertical Signal Integrity of Tissue Slices

Diagnose und Therapie der MASLD

Key takeaways from the updated multidisciplinary European MASLD guidelines

A bioenergetic basis for multiorgan dysfunction in sepsis

Association of the Genetic Variant VEGFA rs3025039 with Incidence and Prognosis of Cholangiocarcinoma

Machine Learning Models predicting Decompensation in Cirrhosis

Metabolic reprogramming in liver fibrosis

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary

EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

C-C chemokine receptor type 7 (CCR7) regulates hepatic CD8+ T cell homeostasis and response to acute liver injury

C-C chemokine receptor type 7 (CCR7) regulates hepatic CD8+ T cell homeostasis and response to acute liver injury

Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis

Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis

The senescent secretome drives PLVAP expression in cultured human hepatic endothelia to promote monocyte transmigration

Unboxing the cell-type specific contribution of endoplasmic reticulum stress to NASH pathophysiology—myeloid X-box-binding protein 1 as a driver of steatohepatitis and fibrosis

Associations of Betatrophin/ANGPTL8 with Septic Dyslipidemia in Human Peritonitis: An Explorative Analysis

Detection of Liver Dysfunction Using a Wearable Electronic Nose System Based on Semiconductor Metal Oxide Sensors

Nonalcoholic Fatty Liver Disease

Endoplasmic reticulum stress and the unfolded protein response in skeletal muscle of subjects suffering from peritoneal sepsis

PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

Editorial: re‐thinking cardiovascular risk factors in NAFLD with advanced fibrosis?

Emerging therapeutic targets for NASH: key innovations at the preclinical level

Collaborators (9)

Roland Eils

Rajeshwar Prosad Mookerjee

Emma Shepherd

Moritz Peiseler

Christoph Sponholz

Jens Haueisen

Wim Laleman

Frank Tacke

Juan Acevedo

Make your next move.